— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...

Advances 5x30 strategy by expanding pipeline with a highly complementary asset that has the potential to provide several days ...

Opioids were once the go-to solution for surgical pain relief, but unwanted side effects like nausea, dizziness, constipation ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Ultrasound-guided peripheral nerve blocks have a higher success rate compared to nerve stimulation or other methods, according to a study conducted by the Department of Anesthesiology at Johns Hopkins ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com. For those ...